Genetic Expression Alteration Affect on Lateral Neck Node Metastasis of Thyroid Papillary Microcarcinoma : Microarray Analysis
NCT ID: NCT01384669
Last Updated: 2019-03-28
Study Results
Results pending
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
Recruitment Status
COMPLETED
Total Enrollment
29 participants
Study Classification
OBSERVATIONAL
Study Start Date
2011-05-31
Study Completion Date
2013-05-26
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this study, the investigators look at the genetic expressional alteration which influenced on the early lateral neck node metastasis in thyroid papillary microcarcinoma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Genomic Predictors of Papillary Microcarcinoma Disease Progression
NCT02363595
Papillary Microcarcinoma
RECRUITING
IDEntification of New Predisposition Genes in Differentiated THYroid Cancer
NCT05014698
Differentiated Thyroid Cancer
Thyroid Cancer, Nonmedullary
TERMINATED
NA
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Advanced Thyroid Cancer Patients (TOPICS-THYROID)
NCT05541380
Thyroid Cancer
ACTIVE_NOT_RECRUITING
Molecular Markers in Thyroid Cancer
NCT00598364
Thyroid Cancer
COMPLETED
Epigenetic Changes in Head and Neck Cancer
NCT04260074
Head and Neck Cancer
Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma
+1 more
COMPLETED
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Papillary thyroid carcinomas (PTCs) measuring 1.0 cm or less in diameter were defined as papillary thyroid microcarcinomas (PTMCs) by the World Health Organization (WHO), emphasizing on their benign behavior, probably of little clinical significance, which do not affect patients' survival. However, some reported that PTMCs may have aggressive behavior, can cause locoregional recurrences, cervical lymph node metastases, and even distant metastases. But till now, the characteristics of PTMCs with early lateral neck node metastasis were only reviewed and described by the clinicopathological parameters, and no analysis of PTMCs by the gene level is available. In these study, we investigate the genetic expressional alteration which influenced on the early lateral neck node metastasis in thyroid papillary microcarcinoma.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Papillary Thyroid Microcarcinoma
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
Observational Model Type
CASE_CONTROL
Study Time Perspective
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
papillary thyroid microcarcinoma without lymph node metastasis
No interventions assigned to this group
Group 2
papillary thyroid microcarcinoma with lateral lymph node metastasis
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age≥20 years old
* Conventional type papillary thyroid microcarcinoma (0.5cm≤tumor size≤1.0cm)
* group 1: no lymph node metastasis /group 2: with lateral neck node metastasis
* Conventional type papillary thyroid microcarcinoma (0.5cm≤tumor size≤1.0cm)
* group 1: no lymph node metastasis /group 2: with lateral neck node metastasis
Exclusion Criteria
* tumor with capsular invasion (T3 tumor)
* distant metastasis
* combined underlying thyroiditis
* distant metastasis
* combined underlying thyroiditis
Minimum Eligible Age
20 Years
Eligible Sex
ALL
Accepts Healthy Volunteers
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Sponsor Role
lead
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Responsibility Role
SPONSOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Severance Hospital
Seoul, , South Korea
Site Status
Countries
Review the countries where the study has at least one active or historical site.
South Korea
References
Explore related publications, articles, or registry entries linked to this study.
Yin DT, Wang L, Sun J, Yin F, Yan Q, Shen R, He G, Gao JX. Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma. Int J Clin Exp Pathol. 2010 May 25;3(5):482-91.
Reference Type
RESULT
Moses W, Weng J, Khanafshar E, Duh QY, Clark OH, Kebebew E. Multiple genetic alterations in papillary thyroid cancer are associated with younger age at presentation. J Surg Res. 2010 May 15;160(2):179-83. doi: 10.1016/j.jss.2009.05.031. Epub 2009 Jun 17.
Reference Type
RESULT
Salehian B, Liu Z. Genetic alterations in differentiated thyroid cancers. Endocr Metab Immune Disord Drug Targets. 2009 Sep;9(3):257-68. doi: 10.2174/187153009789044338. Epub 2009 Sep 1.
Reference Type
RESULT
Ringel MD. Molecular markers of aggressiveness of thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2009 Oct;16(5):361-6. doi: 10.1097/MED.0b013e32832ff2cb.
Reference Type
RESULT
Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A. A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery. 2004 Feb;135(2):139-48. doi: 10.1016/s0039-6060(03)00384-2.
Reference Type
RESULT
Hedinger C, Williams ED, Sobin LH. The WHO histological classification of thyroid tumors: a commentary on the second edition. Cancer. 1989 Mar 1;63(5):908-11. doi: 10.1002/1097-0142(19890301)63:53.0.co;2-i.
Reference Type
RESULT
Chow SM, Law SC, Au SK, Mang O, Yau S, Yuen KT, Lau WH. Changes in clinical presentation, management and outcome in 1348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960-2000. Clin Oncol (R Coll Radiol). 2003 Sep;15(6):329-36. doi: 10.1016/s0936-6555(03)00066-9.
Reference Type
RESULT
Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH. Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer. 2003 Jul 1;98(1):31-40. doi: 10.1002/cncr.11442.
Reference Type
RESULT
Hay ID, Grant CS, van Heerden JA, Goellner JR, Ebersold JR, Bergstralh EJ. Papillary thyroid microcarcinoma: a study of 535 cases observed in a 50-year period. Surgery. 1992 Dec;112(6):1139-46; discussion 1146-7.
Reference Type
RESULT
Noguchi S, Yamashita H, Murakami N, Nakayama I, Toda M, Kawamoto H. Small carcinomas of the thyroid. A long-term follow-up of 867 patients. Arch Surg. 1996 Feb;131(2):187-91. doi: 10.1001/archsurg.1996.01430140077021.
Reference Type
RESULT
Yamashita H, Noguchi S, Murakami N, Toda M, Uchino S, Watanabe S, Kawamoto H. Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer. 1999 Sep 1;86(5):842-9. doi: 10.1002/(sici)1097-0142(19990901)86:53.0.co;2-x.
Reference Type
RESULT
Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y. Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg. 2003 Mar;237(3):399-407. doi: 10.1097/01.SLA.0000055273.58908.19.
Reference Type
RESULT
Lee X, Gao M, Ji Y, Yu Y, Feng Y, Li Y, Zhang Y, Cheng W, Zhao W. Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma. Ann Surg Oncol. 2009 Feb;16(2):240-5. doi: 10.1245/s10434-008-0233-3. Epub 2008 Nov 26.
Reference Type
RESULT
Kebebew E, Weng J, Bauer J, Ranvier G, Clark OH, Duh QY, Shibru D, Bastian B, Griffin A. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann Surg. 2007 Sep;246(3):466-70; discussion 470-1. doi: 10.1097/SLA.0b013e318148563d.
Reference Type
RESULT
Rodolico V, Cabibi D, Pizzolanti G, Richiusa P, Gebbia N, Martorana A, Russo A, Amato MC, Galluzzo A, Giordano C. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid <or=1 cm and their paired lymph node metastases. Cancer. 2007 Sep 15;110(6):1218-26. doi: 10.1002/cncr.22912.
Reference Type
RESULT
Eun YG, Kim SW, Kim YW, Kwon KH. Loss of Raf-1 kinase inhibitor protein expression is associated with lymph node metastasis in papillary thyroid cancer. Otolaryngol Head Neck Surg. 2010 Oct;143(4):544-8. doi: 10.1016/j.otohns.2010.05.025. Epub 2010 Aug 21.
Reference Type
RESULT
Oler G, Camacho CP, Hojaij FC, Michaluart P Jr, Riggins GJ, Cerutti JM. Gene expression profiling of papillary thyroid carcinoma identifies transcripts correlated with BRAF mutational status and lymph node metastasis. Clin Cancer Res. 2008 Aug 1;14(15):4735-42. doi: 10.1158/1078-0432.CCR-07-4372.
Reference Type
RESULT
Vasko V, Espinosa AV, Scouten W, He H, Auer H, Liyanarachchi S, Larin A, Savchenko V, Francis GL, de la Chapelle A, Saji M, Ringel MD. Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2803-8. doi: 10.1073/pnas.0610733104. Epub 2007 Feb 12.
Reference Type
RESULT
Yasuoka H, Nakamura Y, Zuo H, Tang W, Takamura Y, Miyauchi A, Nakamura M, Mori I, Kakudo K. VEGF-D expression and lymph vessels play an important role for lymph node metastasis in papillary thyroid carcinoma. Mod Pathol. 2005 Aug;18(8):1127-33. doi: 10.1038/modpathol.3800402.
Reference Type
RESULT
Zou M, Famulski KS, Parhar RS, Baitei E, Al-Mohanna FA, Farid NR, Shi Y. Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma. J Clin Endocrinol Metab. 2004 Dec;89(12):6146-54. doi: 10.1210/jc.2004-0418.
Reference Type
RESULT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4-2011-0212
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.
Chemotherapy on Methylation Patterns in Breast Tumor Tissue Correlating With Clinical Response and Outcomes
NCT00698477
UNKNOWN
Molecular and Genomic Profiling of Head and Neck Tumors
NCT00200486
RECRUITING
Role of NGS-based ThyroSeq Panel in Cancer Diagnosis in Thyroid Nodules
NCT02352766
COMPLETED
Different Genetic Features Associated With Hepatic Carcinogenesis
NCT01247506
UNKNOWN
Proteomics of Papillary Thyroid Carcinoma
NCT02814032
UNKNOWN
Association Between Multiple Coagulation-related Factors and Lymph Node Metastasis in Patients With Gastric Cancer: A Retrospective Cohort Study
NCT05592925
UNKNOWN
Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools
NCT04626440
RECRUITING
Methylation Biomarkers for Pioneering Early Esophageal Cancer Detection
NCT06895551
COMPLETED
DNA Analysis of Tissue Samples From Patients With Head and Neck Cancer
NCT00898664
COMPLETED
A Gene Hunting Study for Familial Papillary Thyroid Cancer
NCT02776969
ACTIVE_NOT_RECRUITING
Biomarkers in Patients With Head and Neck Cancer
NCT01466257
COMPLETED
Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type
NCT04285476
ACTIVE_NOT_RECRUITING
NA
Specific Methylation Profiles in HNSCC
NCT04567056
RECRUITING
Circulating Tumor DNA and BRCA Reversion Mutation in Advanced or Recurrent Ovarian Cancer Patients With Germline Mutation.
NCT05458973
UNKNOWN
Study of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals Patients
NCT01424878
COMPLETED
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
NCT01109420
RECRUITING
Gene Expression Profiles in Predicting Survival of Patients With Head and Neck Cancer
NCT00897052
COMPLETED
Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer
NCT00898742
TERMINATED
Hereditary Risk Factors for Thyroid Cancer
NCT02747888
RECRUITING
NA
Detection of Germline and Somatic Pathogenic Variants in Patients With de Novo Metastatic Breast Cancer
NCT05758948
UNKNOWN
International Cancer of the Head and Neck, Genetics and Environment (InterCHANGE) Study
NCT01972802
UNKNOWN
Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer
NCT05463107
RECRUITING
Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301
NCT01487733
COMPLETED
Establishment of a Microfluidic Based Liquid Biopsy Platform for Recurrent/Metastatic Head and Neck Cancers Prognostication Using NK Cell IFN-γ Expression and CTM Correlation With DS-SACA Chip
NCT06678724
NOT_YET_RECRUITING
Percentage of BRAFV600E Alleles and Outcome in Thyroid Carcinoma
NCT04664413
UNKNOWN